References
- PeyvandiFMenegattiMPallaRRare bleeding disorders: worldwide efforts for classification, diagnosis, and managementSemin Thromb Hemost201339657958423888434
- MannucciPMTuddenhamEGThe hemophilias – from royal genes to gene therapyN Engl J Med2001344231773177911396445
- PeyvandiFDugaSAkhavanSMannucciPMRare coagulation deficienciesHaemophilia20028330832112010428
- MarianiGHerrmannFHDolceAClinical phenotypes and factor VII genotype in congenital factor VII deficiencyThromb Haemost200593348148715735798
- NapolitanoMdi MinnoMNBatorovaAWomen with congenital factor VII deficiency: clinical phenotype and treatment options from two international studiesHaemophilia201622575275927338009
- PeyvandiFPallaRMenegattiMCoagulation factor activity and clinical bleeding severity in rare bleeding disorders: results from the European Network of Rare Bleeding DisordersJ Thromb Haemost201210461562122321862
- HerrmannFHWulffKAuerswaldGFactor VII deficiency: clinical manifestation of 717 subjects from Europe and Latin America with mutations in the factor 7 geneHaemophilia200915126728018976247
- McveyJHBoswellEMumfordADKemball-CookGTuddenhamEGFactor VII deficiency and the FVII mutation databaseHum Mutat200117131711139238
- LapecorellaMMarianiGInternational Registry on Congenital Factor VII DeficiencyFactor VII deficiency: defining the clinical picture and optimizing therapeutic optionsHaemophilia20081461170117519141157
- PallaRPeyvandiFShapiroADRare bleeding disorders: diagnosis and treatmentBlood2015125132052206125712993
- PerryDJFactor VII deficiencyBlood Coagul Fibrinolysis200314Suppl 1S47S5414567537
- Giansily-BlaizotMVerdierRBiron-AdréaniCAnalysis of biological phenotypes from 42 patients with inherited factor VII deficiency: can biological tests predict the bleeding risk?Haematologica200489670470915194538
- CramerTJAndersonKNavazKBrownJMMosnierLOvon DrygalskiAHeterozygous congenital Factor VII deficiency with the 9729del4 mutation, associated with severe spontaneous intracranial bleeding in an adolescent maleBlood Cells Mol Dis20165781226852649
- PeyvandiFdi MicheleDBolton-MaggsPHClassification of rare bleeding disorders (RBDs) based on the association between coagulant factor activity and clinical bleeding severityJ Thromb Haemost20121091938194322943259
- Di MinnoMNDolceAMarianiGSTER Study GroupBleeding symptoms at disease presentation and prediction of ensuing bleeding in inherited FVII deficiencyThromb Haemost201310961051105923571462
- JamesPSalomonOMikovicDPeyvandiFRare bleeding disorders – bleeding assessment tools, laboratory aspects and phenotype and therapy of FXI deficiencyHaemophilia201420Suppl 4717524762279
- HighamJMO’BrienPMShawRWAssessment of menstrual blood loss using a pictorial chartBr J Obstet Gynaecol19909787347392400752
- SrámekAEikenboomJCBriëtEVandenbrouckeJPRosendaalFRUsefulness of patient interview in bleeding disordersArch Intern Med199515513140914157794090
- SadlerJERodeghieroFISTH SSC Subcommittee on von Willebrand FactorProvisional criteria for the diagnosis of VWD type 1J Thromb Haemost20053477577715842361
- RodeghieroFCastamanGTosettoAThe discriminant power of bleeding history for the diagnosis of type 1 von Willebrand disease: an international, multicenter studyJ Thromb Haemost20053122619262616359502
- RodeghieroFTosettoAAbshireTISTH/SSC bleeding assessment tool: a standardized questionnaire and a proposal for a new bleeding score for inherited bleeding disordersJ Thromb Haemost2010892063206520626619
- BowmanMMundellGGrabellJGeneration and validation of the Condensed MCMDM-1VWD Bleeding Questionnaire for von Willebrand diseaseJ Thromb Haemost20086122062206618983516
- TosettoACastamanGPlugIRodeghieroFEikenboomJProspective evaluation of the clinical utility of quantitative bleeding severity assessment in patients referred for hemostatic evaluationJ Thromb Haemost2011961143114821435168
- ForsythALGregoryMNugentDHaemophilia Experiences, Results and Opportunities (HERO) Study: survey methodology and population demographicsHaemophilia2014201445123902228
- NugentDKalninsWQuerolFHaemophilia Experiences, Results and Opportunities (HERO) study: treatment-related characteristics of the populationHaemophilia2015211e26e3825377442
- CassisFRBuzziAForsythAHaemophilia Experiences, Results and Opportunities (HERO) Study: influence of haemophilia on interpersonal relationships as reported by adults with haemophilia and parents of children with haemophiliaHaemophilia2014204e287e29524800872
- CassisFRQuerolFForsythAIorioAHERO International Advisory BoardPsychosocial aspects of haemophilia: a systematic review of methodologies and findingsHaemophilia2012183e101e11422059839
- BucknerTWWitkopMGuelcherCManagement of US men, women, and children with hemophilia and methods and demographics of the Bridging Hemophilia B Experiences, Results and Opportunities into Solutions (B-HERO-S) studyEur J Haematol201798Suppl 8651728319338
- CutterSMolterDDunnSImpact of mild to severe hemophilia on education and work by US men, women, and caregivers of children with hemophilia B: The Bridging Hemophilia B Experiences, Results and Opportunities into Solutions (B-HERO-S) studyEur J Haematol201798Suppl 86182428319337
- BuzziAKelleyLGregoryMSkinnerMKalninsWImproving comprehensive care in the haemophilia community: building on the HERO StudyHaemophilia2016224e320e32227170451
- MarianiGHerrmannFHBernardiFSchvedJFAuerswaldGIngerslevJClinical manifestations, management, and molecular genetics in congenital factor VII deficiency: the International Registry on Congenital Factor VII Deficiency (IRF7)Blood2000961374
- MarianiGDolceABatorovaARecombinant, activated factor VII for surgery in factor VII deficiency: a prospective evaluation – the surgical STERBr J Haematol2011152334034621158750
- MarianiGNapolitanoMDolceAReplacement therapy for bleeding episodes in factor VII deficiency. A prospective evaluationThromb Haemost2013109223824723238632
- NapolitanoMDolceABatorovaAReplacement therapy in inherited factor VII deficiency: occurrence of adverse events and relation with surgeryHaemophilia2015216e513e51726249164
- NapolitanoMGiansily-BlaizotMDolceAProphylaxis in congenital factor VII deficiency: indications, efficacy and safety. Results from the Seven Treatment Evaluation Registry (STER)Haematologica201398453854423403322
- di MinnoMNAmbrosinoPMyasoedovaVRecombinant activated factor VII (Eptacog Alfa Activated, NovoSeven®) in patients with rare congenital bleeding disorders. a systematic review on its use in surgical proceduresCurr Pharm Des20172371125113128034354